Data / Drug companies / WellSpring Pharmaceutical Corporation
WellSpring Pharmaceutical Corporation: 29 products in the FDA NDC directory, labeler code 65197
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
WellSpring Pharmaceutical Corporation (labeler code 65197) lists 29 products in the FDA National Drug Code Directory, covering 18 finished drugs by generic name. By type: 29 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on June 15, 2026.
The request: Watch WellSpring Pharmaceutical Corporation (FDA labeler code 65197): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 65197
- Products in commercial distribution
- 29
- Packages
- 50
- Finished drugs by generic name
- 18
- Prescription products
- 0
- Over the counter products
- 29
- Flagged as original packager
- 28 of 28 products that carry the flag
- Started marketing in the last 12 months
- 1
- Products with a marketing end date set
- 3
- Earliest marketing start
- September 24, 2008
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 23 | 79.3% |
| Other unapproved drugs | 6 | 20.7% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 29 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Meclizine hydrochloride | 4 | 41 |
| Lidocaine | 4 | 216 |
| Sodium citrate dihydrate | 4 | 4 |
| Phosphorated carbohydrate | 2 | 3 |
| Solarcaine burn pain relief 4oz | 2 | 1 |
| Childrens emetrol multi-symptom upset stomach relief | 1 | 1 |
| Lidocaine hydrochloride | 1 | 134 |
| Ad overnight healing | 1 | 1 |
| Ad anti-chafing | 1 | 1 |
| Alumina, magnesia, simethicone | 1 | 1 |
| Ad skin protectant | 1 | 1 |
| Fds intimate whole body medicated chafing | 1 | 1 |
| Benzalkonium chloride and lidocaine hydrochloride | 1 | 9 |
| Ad first aid multipurpose | 1 | 1 |
| Ad prevent original | 1 | 1 |
| Bactine max wound wash | 1 | 1 |
| Miconazole nitrate | 1 | 101 |
| Ad medicated rash | 1 | 1 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, chewable | 9 | 31% |
| Ointment | 8 | 27.6% |
| Liquid | 5 | 17.2% |
| Spray | 3 | 10.3% |
| Solution | 2 | 6.9% |
| Powder, for solution | 1 | 3.4% |
| Cream | 1 | 3.4% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Childrens Emetrol Multi Symptom Upset Stomach Relief | 65197-230 | Tablet, chewable | Over the counter monograph drugs | June 15, 2026 |
| Bonine | 65197-297 | Tablet, chewable | Over the counter monograph drugs | April 1, 2025 |
| AD Anti-Chafing | 65197-408 | Ointment | Over the counter monograph drugs | February 23, 2025 |
| FDS intimate Whole Body Medicated Chafing | 65197-730 | Ointment | Over the counter monograph drugs | January 31, 2025 |
| AD Skin Protectant | 65197-470 | Ointment | Over the counter monograph drugs | January 20, 2025 |
| AD Medicated Rash | 65197-406 | Ointment | Over the counter monograph drugs | January 15, 2025 |
| Solarcaine Burn Pain Relief 4oz | 65197-512 | Spray | Over the counter monograph drugs | November 15, 2024 |
| Bactine Max Bandage | 65197-830 | Liquid | Over the counter monograph drugs | August 31, 2024 |
| AD Overnight Healing | 65197-404 | Ointment | Over the counter monograph drugs | May 24, 2024 |
| Bactine Max Lidocaine Roll-on 2.5oz | 65197-840 | Liquid | Over the counter monograph drugs | January 15, 2024 |
| Bactine Max Antibiotic and Lidocaine Max Pain Relief | 65197-827 | Ointment | Over the counter monograph drugs | January 15, 2024 |
| Solarcaine Burn Pain Relief 4oz | 65197-502 | Spray | Over the counter monograph drugs | January 1, 2024 |
| Emetrol Powder Non-Drowsy | 65197-203 | Powder, for solution | Other unapproved drugs | December 1, 2023 |
| AD PREVENT Original | 65197-401 | Ointment | Over the counter monograph drugs | October 2, 2023 |
| AD First Aid Multipurpose | 65197-400 | Ointment | Over the counter monograph drugs | September 30, 2023 |
| Emetrol Chewables Mixed Berry | 65197-420 | Tablet, chewable | Other unapproved drugs | July 1, 2023 |
| Emetrol Chewables Orange | 65197-410 | Tablet, chewable | Other unapproved drugs | July 1, 2023 |
| Emetrol Children Mixed Berry | 65197-202 | Solution | Other unapproved drugs | June 1, 2023 |
| Bactine max | 65197-820 | Liquid | Over the counter monograph drugs | April 15, 2023 |
| Bonine max | 65197-520 | Tablet, chewable | Over the counter monograph drugs | March 24, 2023 |
| Bonine | 65197-296 | Tablet, chewable | Over the counter monograph drugs | February 15, 2023 |
| Bactine Max Dry | 65197-815 | Spray | Over the counter monograph drugs | January 31, 2023 |
| Bactine Max | 65197-832 | Liquid | Over the counter monograph drugs | April 1, 2022 |
| Emetrol Chewables | 65197-204 | Tablet, chewable | Other unapproved drugs | March 15, 2022 |
| Bactine Max | 65197-811 | Liquid | Over the counter monograph drugs | June 22, 2018 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.